Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Varian, a Siemens Healthineers Company
PMV Pharmaceuticals, Inc
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
UMC Utrecht
University of Chicago
Aktis Oncology, Inc.
Tubulis GmbH
University of California, Irvine
Eli Lilly and Company
ViroMissile, Inc.
Hospices Civils de Lyon
University Health Network, Toronto
Duke University
Washington University School of Medicine
Tizona Therapeutics, Inc
IDEAYA Biosciences
University of Colorado, Denver
Institut Curie
Daiichi Sankyo
SN BioScience
Oscotec Inc.
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Onchilles Pharma Inc
Elephas
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Novartis
The Netherlands Cancer Institute
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
University of Illinois at Chicago
Pfizer
BicycleTx Limited
Bolt Biotherapeutics, Inc.
Rutgers, The State University of New Jersey
Astellas Pharma Inc
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
ITM Oncologics GmbH
Actym Therapeutics, Inc.
Maastricht University Medical Center
Maastricht Radiation Oncology
LigaChem Biosciences, Inc.
British Columbia Cancer Agency
Washington University School of Medicine